Feasibility of a Smartphone Kiosk intervention to increase HPV vaccination

 描述(申请人提供)：真实预防(RP)是一家有限责任公司，致力于将创新技术商业化，以提供循证健康促进实践。RP在使用叙事策略设计以文化为基础的预防干预措施方面的传播专长导致有效的健康信息，以吸引低知识、低意识和抵触情绪的受众。RP将与圣安德鲁发展(STA)和计划生育(PP)合作，评估作为第一阶段SBIR的一部分，向计划生育(PP)客户推广HPV免疫接种的智能信息亭干预的可行性。HPV感染是美国第二昂贵的性传播感染，占HPV发病率的第二位，并与宫颈癌、肛门癌和口咽癌有关。HPV疫苗接种在美国停滞不前，在PP人群中保持在10%以下。鉴于接种疫苗的好处已得到证实，而且作为主要障碍之一的认识水平较低，重要的是确定新的渠道来传播有效的疫苗信息。这项研究将允许PP利用STA的混合信息亭、短信和移动网站技术来克服疫苗接种障碍，降低癌症风险。PP使未参保的患者免费获得疫苗，并以折扣价格向投保人提供疫苗。这款有望给预防领域带来革命性变革的独特智能手机Kiosk产品的关键属性是：(1)在Kiosk上传递的叙事性(讲故事形式)视频信息，吸引观众并宣传最初的疫苗接种；(2)由Kiosk驱动的及时和个性化的文本和移动网站消息，以确保在患者离开诊所后通过个性化疫苗提醒消息跟踪和完成三个系列的疫苗接种。使用由文本和基于网络的消息强化的Kiosk消息有望显著增加HPV疫苗的启动和系列完成，从而减少HPV感染。该系统的报文将基于形成性研究和试点测试，然后接受独立的可用性测试。一旦可行性被测试，智能手机自助服务亭产品的可扩展性和广泛传播就被结构化地构建在研究的设计中，因为在每个州运营类似的PP候机室都使用Kiosk登记，并且近100%的PP客户使用手机，其中大多数是智能手机用户。可扩展性和有效性将在国家随机对照试验的第二阶段进行测试。PP表达了对全国分销的热情，STA将把这种预防产品的覆盖范围扩大到其他现有的服务于妇女健康的客户。随着PP和这个扩展市场的发展，RP的干预亭智能手机应用程序的商业化潜力巨大。

 DESCRIPTION (provided by applicant): REAL Prevention (RP) is a LLC dedicated to commercializing innovative technologies for delivering evidence-based health promotion practices. RP's communication expertise in designing culturally-grounded prevention interventions using narrative strategies results in effective health messages to engage low knowledge, low awareness and resistant audiences. In partnership with St. Andrew Development (StA) and Planned Parenthood (PP), RP will assess the feasibility of a Smartphone kiosk intervention promoting HPV immunization to Planned Parenthood (PP) clients as part of a Phase I SBIR. HPV infection is the second most costly sexually transmitted infection in the U.S. accounting for HPV morbidity and linked cervical, anogenital, and oropharyngeal cancers. Vaccination for HPV has stagnated in the U.S., remaining lower than 10 percent in the PP population. Given the demonstrated benefit to vaccinating and the low level of awareness that serves as one of the primary barriers, it is important to identify new channels for communicating effective vaccine messages. This study will allow PP, which makes the vaccine available to uninsured patients at no cost and to the insured at a discounted cost, to harness StA's hybrid kiosk, text message, and mobile website technology to overcome vaccination barriers and reduce cancer risk. Key attributes of the unique Smartphone kiosk product that promises to revolutionize the prevention field are: (1) narrative (story-telling form) video messages delivered on kiosks that engage the audience and promote initial vaccination and (2) timely and personalized kiosk-driven text and mobile website messages to insure follow up and completion of the three-series vaccination through personalized vaccine reminder messages after the patients leave the clinic. The use of kiosk messages reinforced by text and web-based messages promises to significantly increase HPV vaccine initiation and series completion thereby, reducing HPV infection. Messages for this system will be based on formative research and piloted tested before being subjected to an independent usability test. Scalability and widespread dissemination of the Smartphone kiosk product is structurally built into the design of the study once feasibility is tested because PP waiting rooms operating similarly in every state utilize kiosk check-in and close to 100 percent of PP clients use mobile phones with a majority being Smartphone users. Scalability and efficacy will be tested in Phase II in a national randomized controlled trial. PP expresses enthusiasm about national distribution and StA will extend the reach of this prevention product to other existing clients serving women's health. The commercialization potential of RP's intervention kiosk Smartphone application is great with the PP and this extended market.